Researchers at the University of Windsor unveiled a high-resolution imaging machine Thursday that they say will immediately impact eight cutting-edge cancer research programs.
The new FluorChem-HD2 imaging system was made possible by a $15,000 donation from Caesars Windsor through its Concerts for a Cure campaign. It can analyze DNA, RNA and protein collected from cells and tissues which is critical to cancer research.
Susanne Tomkins, Caesars’ manager of public relations and communications, noted that since 1994, the casino has donated “over $8 million to local organizations fighting the fight against cancer.”
After formal remarks concluded in the lobby of the university’s Essex Centre of Research (CORe), Dr. Bre-Anne Fifield showed Tomkins and others how the new equipment worked, displaying an image of a fragment of DNA in minutes.
Fifield and Dr. Dora Cavallo Medved are members of the Windsor Cancer Research Group and were on hand Thursday to explain the new equipment’s importance and impact.
Fifield said it will have “immediate and lasting benefits to our cancer research programs here,” and added “this is the type of equipment that is vital for our research programs.”
Medved described it as “a major contribution” one “that will help expand and advance our biomedical research facilities and ultimately will lead to new and innovative solutions in diagnostics and treatment that will impact patients across Windsor-Essex.”
Medved said the imager offers “the best in class resolution.”
She said the previous imaging equipment the WCRG used was housed in another building on campus and didn’t offer the same standard of resolution.
Images from the older equipment might miss proteins and RNA “that are there but we just don’t see it,” she said.
Medved said less than 20 years ago, researchers were actually using photographs to collect images.
“We had a dark room to develop the film and it took hours,” she said.
These newer detailed images will allow researchers “to better understand what the role of the cell is and what’s happening inside those cells.”
Medved equated their work to that of a detective.
“We need all the pieces of evidence,” she said.
Eventually, the researchers will analyze patient samples with the imager in order to offer targeted treatment.
The equipment is multidisciplinary and will be made available to 50 health research scientists.
Source: The Windsor Star
Cancer research benefits from casino charity concerts
A new imaging system unveiled Thursday in the Essex Centre of Research (CORe) will enable high-quality analysis of DNA, RNA, and proteins collected from cells and tissues — benefiting at least eight cutting-edge cancer research programs at the University of Windsor.
The purchase of the FluorChem-HD2 Imaging System was supported by Caesars Windsor, which contributed $10,000 from its Concerts for a Cure campaign and a further $5,000 annual commitment to local cancer programs.
Dora Cavallo Medved, translational research director for the Windsor Cancer Research Group, said those contributions make a difference.
“We are extremely grateful to Caesars Windsor for recognizing the impact of research equipment and its significance to advancing the field,” she said. “Enhancing the infrastructure available for cancer research is critical for moving discovery forward and for training the next generation of scientists and clinicians.”
Susanne Tomkins, the casino’s public relations manager, said the company is honoured to partner with the group, which unites academic cancer researchers from the University of Windsor with clinical researchers at Windsor Regional Hospital, local oncologists, and other health care professionals working in the field of cancer treatment and care.
“We are a long-time proud supporter of the Windsor Cancer Research Group as they continue to strengthen world-renowned cancer research programs here in our community,” Tomkins said.
Source: UWindsor Daily News